Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors

被引：31

作者：

Zbinden, KG ^{[1
]}

Obst-Sander, U ^{[1
]}

Hilpert, K ^{[1
]}

Kühne, H ^{[1
]}

Banner, DW ^{[1
]}

Böhm, HJ ^{[1
]}

Stahl, M ^{[1
]}

Ackermann, J ^{[1
]}

Alig, L ^{[1
]}

Weber, L ^{[1
]}

Wessel, HP ^{[1
]}

Riederer, MA ^{[1
]}

Tschopp, TB ^{[1
]}

Lavé, T ^{[1
]}

机构：

[1] F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 23期

关键词：

D O I：

10.1016/j.bmcl.2005.04.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor Vila inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：5344 / 5352

页数：9

共 50 条

[21] Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors
Parlow, JJ
Kurumbail, RG
Stegeman, RA
Stevens, AM
Stallings, WC
South, MS
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4696 - 4701
[22] Synthesis of 2-pyridones as tissue factor VIIa inhibitors
Parlow, JJ
South, MS
TETRAHEDRON, 2003, 59 (39) : 7695 - 7701
[23] Solid-phase synthesis of napthylamidines as factor VIIa/tissue factor inhibitors.
Backman, BO
Chou, YL
Lentz, D
Liang, A
Light, D
McCarrick, M
Mohan, R
Morrissey, MM
Shaw, KJ
Trinh, L
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U22 - U22
[24] Design and synthesis of conformationally rigid macrocyclic tissue factor-factor VIIa inhibitors
Glunz, Peter W.
Zhang, Xiaojun
Wurtz, Nicholas
Zou, Yan
Delucca, Inda
Parkhurst, Brandon
Cheney, Daniel
Mueller, Luciano
Wei, Anzhi
Luettgen, Joseph M.
Knabb, Robert M.
Harper, Timothy
Wong, Pancras C.
Wexler, Ruth R.
Priestley, E. Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[25] SYNTHETIC SUBSTRATES FOR HUMAN FACTOR-VIIA AND FACTOR-VIIA-TISSUE FACTOR
BUTENAS, S
RIBARIK, N
MANN, KG
BIOCHEMISTRY, 1993, 32 (26) : 6531 - 6538
[26] Discovery of selective and orally bioavailable TACE inhibitors.
Duan, JJW
Chen, LH
Lu, ZH
Wasserman, ZR
Maduskuie, TP
Liu, RQ
Covington, MB
Vaddi, KG
Qian, MX
Voss, ME
Xue, CB
Hardman, KD
Ribadeneira, MD
Newton, RC
Magolda, RL
Christ, DD
Decicco, CP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U81 - U81
[27] Regulation of factor VIIa and factor VIIa-tissue factor by protein C inhibitor
Fortenberry, YM
Cook, AB
Church, FC
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E13 - E14
[28] Discovery of potent and selective biaryl derivatives as tissue factor/factor VIIa inhibitors through structure-based drug design
Chand, P
Kotian, PL
Dehghani, A
El-Kattan, Y
Lin, TH
Wu, MW
Rowland, RS
Raman, K
Bantia, S
Arnold, S
Babu, YS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U153 - U154
[29] The Role of Tissue Factor and Factor VIIa in Hemostasis
Mackman, Nigel
ANESTHESIA AND ANALGESIA, 2009, 108 (05): : 1447 - 1452
[30] Tissue factor-factor VIIa signaling
Rao, LVM
Pendurthi, UR
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) : 47 - 56

← 1 2 3 4 5 →